The stock of iSHARES MSCI BRAZIL INDEX ETF (TSE:XBZ) is a huge mover today! About 20,700 shares traded hands or 273.31% up from the average. iSHARES MSCI BRAZIL INDEX ETF (TSE:XBZ) has risen 26.43% since April 20, 2016 and is uptrending. It has outperformed by 21.02% the S&P500.
The move comes after 9 months negative chart setup for the $16.98M company. It was reported on Nov, 24 by Barchart.com. We have $11.67 PT which if reached, will make TSE:XBZ worth $1.19 million less.
More notable recent iSHARES MSCI BRAZIL INDEX ETF (TSE:XBZ) news were published by: Etfdailynews.com which released: “Brazil’s Massive Stock Rally Will Probably End Soon” on August 04, 2016, also Etfdailynews.com with their article: “BlackRock Sees Enormous Risk in Brazil Indexes Right Now” published on August 10, 2016, Etfdailynews.com published: “Investors Are Hedging Their Bets on This Brazil ETF” on August 23, 2016. More interesting news about iSHARES MSCI BRAZIL INDEX ETF (TSE:XBZ) were released by: Etfdailynews.com and their article: “IMF Says Brazil Needs Major Reforms Now, or Recession Will Continue” published on September 30, 2016 as well as Investorplace.com‘s news article titled: “iShares MSCI Brazil Index (ETF) (EWZ): This Rally Isn’t All That Crazy” with publication date: March 18, 2016.
XBZ.TO Company Profile
iShares MSCI Brazil Index Fund (the Fund) seeks to provide investment results that correspond generally to the price and yield performance of publicly traded securities in the aggregate in the Brazilian market, as measured by the MSCI Brazil Index (the Index). The Index seeks to measure the performance of the Brazilian equity market. The Index is a capitalization-weighted index that aims to capture 85% of the (publicly available) total market capitalization. Component companies are adjusted for available float and must meet objective criteria for inclusion in the Index. The Index is reviewed quarterly.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.